Martin Ndayambaje, Karim Zaher, Hicham Wahnou, Patrick Gad Iradukunda, Thierry Habyarimana, Pierre Gashema, Olivier Uwishema, Enos Moyo, Mohd Imran, Tafadzwa Dzinamarira, Emmanuel Edwar Siddig, Ayman Ahmed, Abdellah Naya, Mounia Oudghiri, Pacifique Ndishimye, Claude Mambo Muvunyi
{"title":"Diagnostic and surveillance strategies for Marburg virus persistence in the male reproductive tract: insights from Ebola and Zika viruses.","authors":"Martin Ndayambaje, Karim Zaher, Hicham Wahnou, Patrick Gad Iradukunda, Thierry Habyarimana, Pierre Gashema, Olivier Uwishema, Enos Moyo, Mohd Imran, Tafadzwa Dzinamarira, Emmanuel Edwar Siddig, Ayman Ahmed, Abdellah Naya, Mounia Oudghiri, Pacifique Ndishimye, Claude Mambo Muvunyi","doi":"10.1080/19396368.2026.2652242","DOIUrl":null,"url":null,"abstract":"<p><p>The recent outbreak of the Marburg virus (MARV) in Rwanda was effectively controlled, but concerns remain regarding the virus's persistence and its long-term effects. MARV can remain in the testes of nonhuman primates, where it harms Sertoli cells and compromises the blood-testis barrier, which may have implications for male infertility. This persistence is aided by immunosuppressive regulatory T cells (Tregs), which allow the virus to evade the immune system. Drawing comparisons with Ebola and Zika viruses, we propose that MARV may contribute to male infertility and recommend further studies on human and nonhuman primate survivors. Quick and precise diagnosis is vital for controlling outbreaks. Current diagnostic methods include RT-PCR, ELISA (for antibody and antigen detection), virus isolation, and electron microscopy. Newer technologies like multiplex real-time PCR and CRISPR-based biosensors (e.g., SHERLOCK) provide faster, more sensitive, and on-site detection, which is especially useful in resource-limited areas. These advancements improve MARV monitoring; however, strict biosafety measures are still necessary due to its classification as a Risk Group 4 pathogen.</p>","PeriodicalId":22184,"journal":{"name":"Systems Biology in Reproductive Medicine","volume":"72 1","pages":"241-251"},"PeriodicalIF":2.0000,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Systems Biology in Reproductive Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/19396368.2026.2652242","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/4/16 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ANDROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The recent outbreak of the Marburg virus (MARV) in Rwanda was effectively controlled, but concerns remain regarding the virus's persistence and its long-term effects. MARV can remain in the testes of nonhuman primates, where it harms Sertoli cells and compromises the blood-testis barrier, which may have implications for male infertility. This persistence is aided by immunosuppressive regulatory T cells (Tregs), which allow the virus to evade the immune system. Drawing comparisons with Ebola and Zika viruses, we propose that MARV may contribute to male infertility and recommend further studies on human and nonhuman primate survivors. Quick and precise diagnosis is vital for controlling outbreaks. Current diagnostic methods include RT-PCR, ELISA (for antibody and antigen detection), virus isolation, and electron microscopy. Newer technologies like multiplex real-time PCR and CRISPR-based biosensors (e.g., SHERLOCK) provide faster, more sensitive, and on-site detection, which is especially useful in resource-limited areas. These advancements improve MARV monitoring; however, strict biosafety measures are still necessary due to its classification as a Risk Group 4 pathogen.
期刊介绍:
Systems Biology in Reproductive Medicine, SBiRM, publishes Research Articles, Communications, Applications Notes that include protocols a Clinical Corner that includes case reports, Review Articles and Hypotheses and Letters to the Editor on human and animal reproduction. The journal will highlight the use of systems approaches including genomic, cellular, proteomic, metabolomic, bioinformatic, molecular, and biochemical, to address fundamental questions in reproductive biology, reproductive medicine, and translational research. The journal publishes research involving human and animal gametes, stem cells, developmental biology and toxicology, and clinical care in reproductive medicine. Specific areas of interest to the journal include: male factor infertility and germ cell biology, reproductive technologies (gamete micro-manipulation and cryopreservation, in vitro fertilization/embryo transfer (IVF/ET) and contraception. Research that is directed towards developing new or enhanced technologies for clinical medicine or scientific research in reproduction is of significant interest to the journal.